A trial looking at BNT327 and chemotherapy for small cell lung cancer (BNT327-03)
Cancer type:
Status:
Phase:
This trial is comparing BNT327 and chemotherapy with atezolizumab and standard chemotherapy.
It is for people having their first treatment for small cell lung cancer that has spread within the chest or to other parts of the body. This is called extensive stage lung cancer. This means that the cancer has spread beyond a single area that can be treated with .
More about this trial
Chemotherapy is one of the main treatments for extensive stage small cell lung cancer. A standard combination of chemotherapy for this type of lung cancer is etoposide and carboplatin. You might have this alongside an such as atezolizumab.
Doctors are looking for ways to improve treatment for extensive stage small cell lung cancer. In this trial, they are looking at an experimental drug called BNT327. It is a new type of It works in 2 ways. It aims to help the
to find and kill cancer cells. Cancer cells need a blood supply to fuel their growth. BNT327 also aims to stop cancer cells from forming new blood vessels.
Doctors are exploring whether adding BNT327 to standard chemotherapy will work better than chemotherapy and atezolizumab. But they don’t know this for sure, so want to find this out.
In this trial, some people will have BNT327 and chemotherapy. And some people have atezolizumab and chemotherapy
The main aims of the trial are to find out:
- whether BNT327 with chemotherapy works better than atezolizumab and chemotherapy
- how safe BNT327 is
- what happens to BNT327 in the body
- how treatment affects your
quality of life
Who can enter
The following bullet points are a summary of the entry conditions for this trial. Talk to your doctor or the trial team if you are unsure about any of these. They will be able to advise you.
Who can take part
You may be able to join this trial if all of the following apply. You:
- have extensive stage small cell lung cancer. This means the cancer has spread within the chest or to other parts of the body. You might also be able to take part if your cancer has spread more widely within the lung and cannot be treated with
chemoradiotherapy . Your doctor will know this.
- have at least one area of cancer that your doctor can measure on a scan
- have satisfactory blood test results
- are fit and active but might not be able to do heavy physical work (performance status 0 or 1)
- are willing to use reliable contraception during the trial and for a period after if there is any chance you or your partner could become pregnant. You must also be willing to not donate or freeze eggs or donate sperm during the trial and for a period after.
- are at least 18 years old
Who can’t take part
Cancer related
You cannot join this trial if any of these apply. You:
- have a mixture of small cell lung cancer cells and other types of cancer cells
- have cancer that has spread to the brain or spinal cord. You can take part if you have had treatment, the cancer has been stable and you stopped taking
steroids within 10 days of starting trial treatment. You can’t take part if the cancer has spread to the thin tissue layers that cover the brain or the cancer in the brain measures more than 2cm across.
- have already had cancer treatment to the whole body for extensive stage small cell lung cancer. You may be able to take part if you have had
chemoradiotherapy ,
immunotherapy , radiotherapy or chemotherapy for
limited stage small cell lung cancer and had no signs of cancer for at least 6 months after the last treatment.
- have already had treatment with BNT327 or a similar drug
- are taking an experimental drug or using a device as part of another clinical trial. This is if it is within 3 weeks of being put in a treatment group for this trial.
- had any serious side effect caused by immunotherapy for another cancer or condition or for limited stage lung cancer that meant you had to stop treatment
- have already had radiotherapy or certain
targeted cancer drugs . This is within 2 to 4 weeks of starting trial treatment. This time period depends on the type of drug you had and where you had radiotherapy. Your doctor will check this. You can take part if you had radiotherapy to the brain or bone.
- have had another cancer in the last 4 years. You can take part if you had successfully treated
carcinoma in situ of the cervix,
ductal carcinoma in situ of the breast,
early bladder cancer, early prostate cancer,
non melanoma skin cancer or papillary thyroid cancer.
Medical conditions
You cannot join this trial if any of these apply. You:
- have had a heart attack or a significant
heart problem within the last 6 months. Your doctor checks your heart before you join the trial.
- have high blood pressure that isn’t well controlled with medication
- have had a major bleeding problem or you have a risk of developing this. Your doctor will know this.
- have a collection of fluid on your lungs, around your heart or in your tummy (abdomen) that needs to be drained often. You might be able to take part if these conditions are stable.
- have a serious wound that isn't healing, an ulcer or a bone
fracture within 6 months of joining the trial. You can’t take part if you had or have a risk of a
fistula in your
abdomen , an abnormal opening between the windpipe and the food pipe, a hole or tear in the gut or a collection of pus in the abdomen in the last 6 months. These conditions must have resolved to take part in the trial.
- have had a sudden life threatening increase in blood pressure or high blood pressure that has affected the brain. Your doctor will know this.
- have had antibiotics as a drip into a vein within 2 weeks of starting trial treatment
- have had major surgery, a significant traumatic injury or an invasive dental procedure such as dental implants within 28 days of starting trial treatment or you plan to have surgery during the trial
- have had a stem cell transplant using donor
stem cells or an
organ transplant in the past
- have an active
autoimmune condition or you have had one in the past apart from certain ones. Your doctor will know about this.
- have had
steroids within 10 days of starting trial treatment unless it was a low dose. Your doctor will know this.
- have HIV, an active hepatitis B or active hepatitis C infection that isn’t well controlled with medication,
tuberculosis or an active syphilis infection
- have moderate to severe side effects from past treatments. You can take part if you have hair loss.
- have symptoms of
spinal cord compression - have a blockage in a large vein in the chest called the superior vena cava. Your doctor will know about this.
- have or had scarring on the lungs or inflammation of the lungs (
pneumonitis ) that needed treatment in the past
- have another medical condition or a mental health condition that could affect you taking part or there is another reason that the trial team don’t think you will be suitable to join this trial.
Other
You cannot join this trial if any of these apply. You:
- are allergic to any of the treatments in the trial or anything they contain
- have had a
live vaccination within 30 days of starting treatment. You can take part if you have had the seasonal flu vaccine or the approved Covid-19 vaccines as these aren’t live.
- are pregnant or breastfeeding or planning to become pregnant during the trial and for a period after
Trial design
This is a phase 3 trial. It is taking place worldwide. The team need 439 people to take part in total.
A computer puts you into a treatment group at random. Neither you nor your doctor will be able to decide which group you are in. And neither you nor your doctor will know which group you are in. They can find this out if necessary.
There are 3 groups. One out of every three people have atezolizumab and chemotherapy. Two out of every three people have BNT327 and chemotherapy. You have 1 of the following:
- atezolizumab and chemotherapy (group 1 - standard treatment)
- a lower dose of BNT327 and standard chemotherapy (group 2)
- a higher dose of BNT327 and standard chemotherapy (group 3)
Please note, there is another clinical trial that is looking at whether a higher or lower dose of BNT327 is better. This is the dose that works best and causes the fewest side effects. When the trial team know this dose, then group 2 or 3 will close to recruitment. People in these groups will be switched over to the other group having BNT327. Your doctor can tell you more about this.
Having treatment
To begin with, everyone has 4 . Each 3 week period is a cycle of treatment. The first day of each treatment cycle is called day one.
In each cycle you have:
- carboplatin on day 1. This is once every 3 weeks.
- etoposide on days 1, 2 and 3
- atezolizumab or BNT327 on day 1. This is once every 3 weeks.
You have all your treatment as a drip into a vein.
BNT327 takes about 90 minutes each time. Your doctor or nurse will monitor you closely the first 2 times you have BNT327. This includes for 30 minutes after the infusion has finished. They will treat any problems straight away.
The trial doctor or nurse will tell you how long it takes to have chemotherapy and atezolizumab.
Everyone then has more treatment for 2 years. If you had BNT327 as part of initial treatment you continue with this. If you had atezolizumab as part of initial treatment you continue with this. You have treatment once every 3 weeks. You have this for up to 2 years as long as it is working and the side effects aren’t too bad.
Samples for research
The researchers might ask to take a tissue sample () if there isn’t a previous sample that they can use. They also ask to take some extra blood samples. Where possible, you have these at the same time as your routine blood tests.
They plan to use the samples to:
- see what happens to BNT327 in the body
- see how well the treatment is working
- look for substances called
biomarkers to help work out why treatment might work for some people and not for others
- check if you are developing
antibodies to BNT327
- look for circulating tumour DNA (
ctDNA ) in the bloodstream
The team will also ask your permission to store some samples for future research. You don’t have to agree to this. It won’t affect you taking part in the rest of the trial.
Quality of life
The trial team ask everyone to fill out some questionnaires:
- before you start treatment
- at set times during and after treatment
The questionnaires ask about side effects and how you are feeling. This is called a quality of life study.
Blood pressure diary
The trial team will ask you to measure your blood pressure at home. You do this once a day, every day. The team will give you a blood pressure machine and explain how to use it. You record the measurement in a paper diary. You will need to bring the diary with you to all the trial visits. Your doctor or nurse will review this.
Hospital visits
You see the doctor for a and you have some tests before you can take part in the trial. These include
- blood tests
- urine tests
- heart trace (ECG)
- heart scan (echocardiogram) or
MUGA scan - a CT scan or an MRI scan
You might have a bone scan if your doctors thinks this is necessary.
You have all your treatment at the hospital in the outpatients department. During treatment you see the doctor regularly. This is for blood tests and to see how you are.
Trial scans
You have a CT scan or MRI scan:
- every 6 weeks for 9 months and then
- every 9 weeks
You stop having the scans as part of the trial if the cancer gets worse or if you start another cancer treatment.
Follow up visits
You see the trial team when you stop treatment for a check up 7 days later and then at:
- 1 month
- 3 months
After that, the trial team will call you once every 3 months to see how you are getting on.
Side effects
The trial team monitor you during treatment and afterwards. Contact your advice line or tell your doctor or nurse if any side effects are bad or not getting better.
BNT327 can affect the These side effects could happen during treatment or months after treatment has finished. Rarely, these side effects could be life threatening. Your doctor or nurse can explain what these side effects are, the risk of them happening and what to look out for. |
BNT327 is a new drug so we don’t know what all the side effects are. The most common side effects of BNT327 we know about so far include:
- a reaction to the drug. This is called an infusion reaction. Signs include a high temperature, chills, shortness of breath, pain, feeling or being sick, feeling dizzy and faint due to low blood pressure or getting headaches due to high blood pressure.
- high levels of protein in the urine
- high blood pressure
- an increased risk of bleeding
- delayed wound healing
We have more information about:
Location
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Chief Investigator
Dr Kevin Franks
Supported by
BioNTech SE
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040